Needles are integral part of healthcare functions. Needles provide advantage over other routes of administration such as quick release of the drug in bodily fluids and instant relief for the patients. It has various applications ranging from surgical use to blood collection to drug administration. Needles such as safety needles are increasingly used in order to avoid needle stick injuries and infection. Needles such as pen needles are used by diabetic patients who need daily dose of insulin which is injected subcutaneously.

Market Dynamics

Major factor driving growth of the needles market is increasing demand for vaccines, globally to prevent various diseases such as measles, rubella and hepatitis B. According to World Health Organization (WHO) 2018, globally around 86% of infants are vaccinated against 26 diseases, however, 19.5 million children unvaccinated leading to death of 2-3 million children each year. Human papilloma virus causes cervical cancer and around 280,000 women died from cervical cancer in 2015 globally, which led to introduction of vaccine to prevent cervical cancer, in turn positively affecting needles market. Introduction of stringent guidelines for safe injection practices is expected to aid in growth of the needles market. For instance, WHO issued safe injection practices and guidelines in 2010, for its member country. Also, Association of Professionals in Infection Control and Epidemiology in the U.S. issued updated guidelines in 2016 to prevent spread of infectious disease through unsafe injection practices.

High prevalence of chronic diseases worldwide is projected to fuel growth of the needles market

Several factors are associated with increasing adoption of needles worldwide. One of the major factors is high prevalence of chronic disease across the world, which is propelling demand for needles. According to the World Health Organization (WHO), in 2017, non-communicable diseases such as cancer, diabetes, cardiovascular diseases, and lung diseases accounted for around 70% death worldwide, which was majorly from middle and low income economies. Furthermore, chronic diseases are expected to account for around 75% of all deaths worldwide by 2020. Therefore, this is expected to aid in market growth, as needle is an integral part of chronic disease treatment. For instance, according to Diabetic Atlas by International Diabetes Federation (IDF), 2017, diabetes affected around 425 million people worldwide. Patients suffering from diabetes require daily administration of insulin with continuous glucose monitoring, which in turn is propelling demand for pen needles. Furthermore, the U.S. majorly invest in treatment of diabetes and cancer, annually. For instance, around US$ 377 Billion are invested, which account for 52% of the total diabetes expenditure worldwide, according to the IDF report 2017. Also, according to World Cancer Research Organization, 2014 report, cancer incidence in the U.S. is one of highest at 328 per 100,000, which is expected to propel growth of the needles market in this region.

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/1331

Growing geriatric population worldwide to drive growth of the global needles market

Rising geriatric population is expected to drive growth of the needles market. As per World Population Prospect, 2017 Revision report by United Nations in 2017, there were 962 million people, under the geriatric category (people aged 60 years and above). By 2030, this is projected to be 1.4 billion increasing at an annual rate of 3%. Geriatric people require frequent hospitalizations due to aging-associated diseases such as heart disease, stroke, diabetes and falling injuries. In certain cases, surgery is required which leads to hospitalization. This is expected to aid in growth of the market. Asia Pacific has a geriatric population of 547 million people, which is expected to reach 900 million geriatric population by 2025. Therefore, manufacturers could focus on expanding in this region. Also, stringent regulations related to safe injection practices by various governments is expected to propel demand for safety needles, in order to reduce chances of contamination from blood borne pathogens, for instance according to report published by WHO in 2014, up to 1.7 million people were infected with hepatitis B virus, up to 315 000 with hepatitis C virus and as many as 33 800 with HIV through an unsafe injection.

Some of the key players operating in the global needles market are Becton, Dickinson and Company, Medtronic plc, Hamilton Company, Stryker Corporation, Terumo Corporation, B. Braun Melsungen AG, Boston Scientific Corporation, Nipro Medical Corporation, Novo Nordisk A/s, Thermo Fisher Scientific, and Smiths Medical.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.


Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]